Literature DB >> 15023527

Induction of apoptosis in cultured endothelial cells by a cadherin antagonist peptide: involvement of fibroblast growth factor receptor-mediated signalling.

Noam Erez1, Eli Zamir, Barbara J Gour, Orest W Blaschuk, Benjamin Geiger.   

Abstract

Cadherins are a family of transmembrane glycoproteins mediating calcium-dependent, homophilic cell-cell adhesion. In addition, these molecules are involved in signaling events, regulating such processes as cell motility, proliferation, and apoptosis. Members of the cadherin subfamily, called either classical or type I cadherins, contain a highly conserved sequence at their homophilic binding site consisting of the three amino acids--histidine-alanine-valine (HAV). Previous studies have shown that peptides containing the HAV motif inhibit cadherin-dependent events such as cell aggregation, compaction, and neurite outgrowth. We report here that a cyclic peptide, N-Ac-CHAVC-NH2 can perturb cadherin-mediated endothelial cell interactions, resulting in a progressive apoptotic cell death. This effect depends on cell density, as it is only observed when dense cultures are treated with the peptide. Adherens junction (AJ)-associated cadherin and catenins are differentially affected by the N-Ac-CHAVC-NH2 treatment, as judged by double immunofluorescence labeling followed by immunofluorescence-ratio imaging. However, cell-cell adhesions are largely retained during the first few hours after addition of the peptide. It was also observed that following treatment, actin filaments partially lose their plasma membrane anchorage at AJs and translocate towards the cell center. Interestingly, addition of basic fibroblast growth factor to confluent, peptide-treated, endothelial cell cultures, completely blocks apoptosis and the inhibitory peptide reduce the phosphorylation of the FGF receptor target protein FRS2, suggesting that the peptide exerts its effect by inhibiting cadherin-mediated activation of fibroblast growth factor receptor signaling. We propose that cadherin-mediated signaling is essential for maintaining viability of confluent endothelial cells, and that its perturbation by N-Ac-CHAVC-NH2 drives these cells to apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15023527     DOI: 10.1016/j.yexcr.2003.11.033

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  15 in total

1.  Soluble N-cadherin fragment promotes angiogenesis.

Authors:  L Derycke; L Morbidelli; M Ziche; O De Wever; M Bracke; E Van Aken
Journal:  Clin Exp Metastasis       Date:  2006-09-22       Impact factor: 5.150

2.  Inhibition of N-cadherin retards smooth muscle cell migration and intimal thickening via induction of apoptosis.

Authors:  Cressida A Lyon; Evgenia Koutsouki; Concepcion M Aguilera; Orest W Blaschuk; Sarah Jane George
Journal:  J Vasc Surg       Date:  2010-07-13       Impact factor: 4.268

Review 3.  Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees.

Authors:  Elisabetta Dejana; Fabrizio Orsenigo; Cinzia Molendini; Peter Baluk; Donald M McDonald
Journal:  Cell Tissue Res       Date:  2008-10-15       Impact factor: 5.249

4.  Soluble N-cadherin overexpression reduces features of atherosclerotic plaque instability.

Authors:  Cressida A Lyon; Jason L Johnson; Helen Williams; Graciela B Sala-Newby; Sarah J George
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-11-13       Impact factor: 8.311

Review 5.  Junctional music that the nucleus hears: cell-cell contact signaling and the modulation of gene activity.

Authors:  Pierre D McCrea; Dongmin Gu; Maria S Balda
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10       Impact factor: 10.005

Review 6.  2b or Not 2b: How Opposing FGF Receptor Splice Variants Are Blocking Progress in Precision Oncology.

Authors:  Richard J Epstein; Li Jun Tian; Yan Fei Gu
Journal:  J Oncol       Date:  2021-04-30       Impact factor: 4.375

7.  A new mouse mutant of the Cdh23 gene with early-onset hearing loss facilitates evaluation of otoprotection drugs.

Authors:  F Han; H Yu; C Tian; H E Chen; C Benedict-Alderfer; Y Zheng; Q Wang; X Han; Q Y Zheng
Journal:  Pharmacogenomics J       Date:  2010-07-20       Impact factor: 3.550

8.  Network modeling of MDM2 inhibitor-oxaliplatin combination reveals biological synergy in wt-p53 solid tumors.

Authors:  Asfar S Azmi; Sanjeev Banerjee; Shadan Ali; Zhiwei Wang; Bin Bao; Frances W J Beck; Main Maitah; Minsig Choi; Tony F Shields; Philip A Philip; Fazlul H Sarkar; Ramzi M Mohammad
Journal:  Oncotarget       Date:  2011-05

9.  N-cadherin in neuroblastoma disease: expression and clinical significance.

Authors:  Tim Lammens; Katrien Swerts; Lara Derycke; Annemie De Craemer; Sara De Brouwer; Katleen De Preter; Nadine Van Roy; Jo Vandesompele; Frank Speleman; Jan Philippé; Yves Benoit; Klaus Beiske; Marc Bracke; Geneviève Laureys
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

10.  Induction of cell-cell fusion by ectromelia virus is not inhibited by its fusion inhibitory complex.

Authors:  Noam Erez; Nir Paran; Galia Maik-Rachline; Boaz Politi; Tomer Israely; Paula Schnider; Pinhas Fuchs; Sharon Melamed; Shlomo Lustig
Journal:  Virol J       Date:  2009-09-29       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.